Coronary Magnetic Resonance Angiography: Technical Innovations Leading Us to the Promised Land?


Journal

JACC. Cardiovascular imaging
ISSN: 1876-7591
Titre abrégé: JACC Cardiovasc Imaging
Pays: United States
ID NLM: 101467978

Informations de publication

Date de publication:
12 2020
Historique:
received: 24 05 2019
revised: 03 01 2020
accepted: 08 01 2020
pubmed: 23 3 2020
medline: 10 8 2021
entrez: 23 3 2020
Statut: ppublish

Résumé

Coronary artery disease remains the leading cause of cardiovascular morbidity and mortality. Invasive X-ray angiography and coronary computed tomography angiography are established gold standards for coronary luminography. However, they expose patients to invasive complications, ionizing radiation, and iodinated contrast agents. Among a number of imaging modalities, coronary cardiovascular magnetic resonance (CMR) angiography may be used in some cases as an alternative for the detection and monitoring of coronary arterial stenosis, with advantages including its versatility, excellent soft tissue characterization, and avoidance of ionizing radiation and iodinated contrast agents. In this review, we explore the recent advances in motion correction, image acceleration, and reconstruction technologies that are bringing coronary CMR angiography closer to widespread clinical implementation.

Identifiants

pubmed: 32199836
pii: S1936-878X(20)30092-9
doi: 10.1016/j.jcmg.2020.01.006
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2653-2672

Subventions

Organisme : British Heart Foundation
ID : FS/CRTF/20/24011
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/12/1/29262
Pays : United Kingdom

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Reza Hajhosseiny (R)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: reza.hajhosseiny@kcl.ac.uk.

Aurelien Bustin (A)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.

Camila Munoz (C)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.

Imran Rashid (I)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.

Gastao Cruz (G)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.

Warren J Manning (WJ)

Department of Medicine (Cardiovascular Division) and Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.

Claudia Prieto (C)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom; Escuela de Ingeniería, Pontificia Universidad Catolica de Chile, Santiago, Chile.

René M Botnar (RM)

School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom; Escuela de Ingeniería, Pontificia Universidad Catolica de Chile, Santiago, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH